Virtu Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.75M Buy
+24,156
New +$1.87M 0.06% 181
2025
Q4
– Sell
-7,117
Closed -$767K – 2300
2025
Q3
$767K Buy
+7,117
New +$775K 0.04% 405
2025
Q2
– Sell
-3,622
Closed -$321K – 2080
2025
Q1
$321K Buy
+3,622
New +$314K 0.02% 643
2022
Q3
– Sell
-1,250
Closed -$52K – 2283
2022
Q2
$52K Buy
1,250
+802
+179% +$54.4K ﹤0.01% 1119
2022
Q1
$45K Sell
448
-709
-61% -$78.8K ﹤0.01% 1164
2021
Q4
$170K Buy
+1,157
New +$258K 0.02% 894
2021
Q3
– Sell
-1,438
Closed -$665K – 2009
2021
Q2
$665K Buy
+1,438
New +$617K 0.06% 348
2021
Q1
– Sell
-350
Closed -$128K – 2073
2020
Q4
$128K Buy
+350
New +$122K 0.01% 994

Other funds holding WGS

Virtu Financial's WGS Position: Q3 2026 in Review

Virtu Financial opened a new position in GeneDx Holdings (WGS) in Q3 2026: 24,156 shares worth $1.75M. The stake represents 0.06% of the portfolio and ranks #181 among its holdings. This is a return to the name: Virtu Financial previously reported a position in WGS as recently as Q3 2025.

Virtu Financial first reported a position in WGS in Q4 2020 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Virtu Financial held 24,156 shares of GeneDx Holdings worth $1.75M as of Q3 2026.
  • GeneDx Holdings was a new Virtu Financial position in Q3 2026.
  • GeneDx Holdings made up 0.06% of Virtu Financial's portfolio in Q3 2026, its #181 holding.
  • Virtu Financial first reported a position in GeneDx Holdings in Q4 2020 and has held it in 8 quarters since.
  • 219 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.